诚信和职业道德。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI:10.1331/108658002763029481

A. Haddad

{"title":"诚信和职业道德。","authors":"A. Haddad","doi":"10.1331/108658002763029481","DOIUrl":null,"url":null,"abstract":"Earlier this year, Kansas City, Mo., pharmacist Robert Courtney admitted to charges that he had adulterated, tampered with, and mislabeled the chemotherapy drugs Taxol (paclitaxel—Bristol-Myers Squibb) and Gemzar (gemcitabine—Lilly) prescribed for 34 patients with cancer. Courtney pleaded guilty to 20 federal counts in an agreement with the government that avoided a","PeriodicalId":17212,"journal":{"name":"Journal of the American Pharmaceutical Association","volume":"8 1","pages":"540-1"},"PeriodicalIF":0.0000,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Trustworthiness and professional ethics.\",\"authors\":\"A. Haddad\",\"doi\":\"10.1331/108658002763029481\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Earlier this year, Kansas City, Mo., pharmacist Robert Courtney admitted to charges that he had adulterated, tampered with, and mislabeled the chemotherapy drugs Taxol (paclitaxel—Bristol-Myers Squibb) and Gemzar (gemcitabine—Lilly) prescribed for 34 patients with cancer. Courtney pleaded guilty to 20 federal counts in an agreement with the government that avoided a\",\"PeriodicalId\":17212,\"journal\":{\"name\":\"Journal of the American Pharmaceutical Association\",\"volume\":\"8 1\",\"pages\":\"540-1\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Pharmaceutical Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1331/108658002763029481\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmaceutical Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1331/108658002763029481","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

今年早些时候，密苏里州堪萨斯城的药剂师罗伯特·考特尼(Robert Courtney)承认，他在34名癌症患者的化疗药物紫杉醇(紫杉醇-百时美施惠宝)和吉西他滨-礼来(Gemzar)中掺假、篡改和贴错标签。考特尼在与政府达成的一项协议中承认了20项联邦罪名

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Trustworthiness and professional ethics.

Earlier this year, Kansas City, Mo., pharmacist Robert Courtney admitted to charges that he had adulterated, tampered with, and mislabeled the chemotherapy drugs Taxol (paclitaxel—Bristol-Myers Squibb) and Gemzar (gemcitabine—Lilly) prescribed for 34 patients with cancer. Courtney pleaded guilty to 20 federal counts in an agreement with the government that avoided a

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of the American Pharmaceutical Association

自引率

0.00%

发文量